Article
Crosstalk between EZH2 and BCL6 in regulating chronic myeloid leukaemia (CML) stem cell survival : from epigenomics to novel therapeutic approaches
2019-01-01
Abstract excerpt
Chronic Myeloid Leukaemia (CML) is a haematopoietic stem cell disorder characterised by the presence of the BCR-ABL1 fusion gene, which produces a constitutively active tyrosine kinase responsible for disease progression. Despite the introduction of tyrosine kinase inhibitors (TKIs) to target this overactive tyrosine kinase, the low cure rate and risk of disease recurrence and progression remains a major clinical...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1ba4806b-9623-5155-bca1-b0a61758aca1
- DOI
- 10.5525/gla.thesis.75174
